Skip to main content

Cabergoline (International)

Note: In some countries, this medicine may only be approved for veterinary use.

In the US, Cabergoline (cabergoline systemic) is a member of the drug class prolactin inhibitors and is used to treat Hyperprolactinemia.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

G02CB03,N04BC06

CAS registry number (Chemical Abstracts Service)

0081409-90-7

Chemical Formula

C26-H37-N5-O2

Molecular Weight

452

Therapeutic Categories

Dopamine agonist

Prolactin inhibitor

Chemical Name

1-[(6-Allylergolin-8β-yl)carbonyl]-1-[(3-(dimetylamino)propyl]-3-etylurea

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs